China Magnesium L-Threonate/ L-Threonic Acid Magnesium Salt 778571-57-6//Gramicidin 1405-97-6//Hemin 16009-13-5//Bronopol 52-51-7//99011-02-6 Imiquimod, Find details about China Imiquimod, 99011-02-6 from Magnesium L-Threonate/ L-Threonic Acid Magnesium Salt 778571-57-6//Gramicidin 1405-97-6//Hemin 16009-13-5//Bronopol 52-51-7//99011-02-6 Imiquimod
Introduction
Product Name | Imiquimod |
MF | C14H16N4 |
MW | 240.31 |
CAS No | 99011-02-6 |
Function
1. It is a genital wart drug, which can be used as an immunomodulator for the treatment of adult genital and perianal condyloma acuminata.
2. Easy to use, good tolerance and unique mechanism of action make it the drug of choice for the treatment of condyloma acuminata
3. In addition, it has been reported that imiquimod can also be used for viral skin diseases such as common warts, flat warts, infectious soft palate, herpes simplex, basal cell carcinoma, Bowen's disease, Bowen's papulosis, actinic angle. Skin tumors such as pathogenic diseases, cutaneous T-cell tumors, and Kaposi's sarcoma may be effective against vitiligo and alopecia areata.
4. Condyloma acuminata is a contagious disease of human herpesvirus (HPV) infection and a major public health threat.
Application
It can be used for the treatment of adult external genital and perianal genital warts at 3 times per week. Just before sleep, first apply the product evenly in a thin layer on the surface of the wart and gently massage until the product is completely absorbed. The position of the medication should not be packeted and should be maintained for 6 to 10 hours, and then wash with a neutral soap and clean water for clearing the drugs in the administration site. Wash your hands before and after treatment. 250 mg of cream can be applied to 20cm2 of wart. Avoid excessive application of the drug. Patients should continue the treatment until the wart is completely cleared. Wart can be cleared within 2-4 week at the fastest speed and can be generally cleared within 8 to 12 weeks. The medication should be not more than 16 weeks. After the treatment, patients with mild erythema locally who does not have to be discontinued for drug; if the patients feel general malaise or get local skin reactions (edema, erosion, pain, etc.), the drug should be discontinued. Only when the reaction is alleviated can they continue the medication.
Specification
Description | White crystalline powder |
Solubility | Tiny dissolve in 0.1mol/L Hcl |
Identification |
|
Assay(on dried basis) | 98~101% |
Purity | ≥99.0% |
Related substances | 1.0% Max |
Heavy metals | 10ppm Max |
Loss on drying | 0.5% Max |
Burning residue | 0.2% Max |